Advanced HER2-Positive Gastric/GEJ Cancers: Expert Insights on Current and Future Strategies

Do you know the latest strategies to optimize care for HER2-positive gastric and gastroesophageal junction (GEJ) cancers?   Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002494?ecd=bdc_podcast_libsyn_mscpedu